This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394424. doi: 10.3322/caac.21492BrayFFerlayJSoerjomataramISiegelRLTorreLAJemalAet alGlobal cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesCA Cancer J Clin20186839442410.3322/caac.21492Open DOISearch in Google Scholar
Vassal G, Fitzgerald E, Schrappe M, Arnold F, Kowalczyk J, Walker D, et al. Challenges for children and adolescents with cancer in Europe: the SIOP-Europe agenda. Pediatr Blood Cancer 2014; 61: 1551-7. doi: 10.1002/ pbc.25044VassalGFitzgeraldESchrappeMArnoldFKowalczykJWalkerDet alChallenges for children and adolescents with cancer in Europe: the SIOP-Europe agendaPediatr Blood Cancer2014611551710.1002/pbc.25044Open DOISearch in Google Scholar
Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel J, et al. Childhood cancer survival in Europe 1999-2007: Results of EUROCARE-5-a population-based study. Lancet Oncol 2014; 15: 35-47. doi: 10.1016/S1470-2045(13)70548-5GattaGBottaLRossiSAareleidTBielska-LasotaMClavelJet alChildhood cancer survival in Europe 1999-2007: Results of EUROCARE-5-a population-based studyLancet Oncol201415354710.1016/S1470-2045(13)70548-5Open DOISearch in Google Scholar
Kowalczyk JR, Samardakiewicz M, Fitzgerald E, Essiaf S, Ladenstein R, Vassal G, et al. Towards reducing inequalities: European standards of care for children with cancer. Eur J Cancer 2014; 50: 481-5. doi: 10.1016/j. ejca.2013.11.004KowalczykJRSamardakiewiczMFitzgeraldEEssiafSLadensteinRVassalGet alTowards reducing inequalities: European standards of care for children with cancerEur J Cancer201450481510.1016/j.ejca.2013.11.004Open DOISearch in Google Scholar
Stary J, Zimmermann M, Campbell M, Castillo L, Dibar E, Donska S, et al. Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002. J Clin Oncol 2014; 32: 174-84. doi: 10.1200/JCO.2013.48.6522StaryJZimmermannMCampbellMCastilloLDibarEDonskaSet alIntensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002J Clin Oncol2014321748410.1200/JCO.2013.48.6522Open DOISearch in Google Scholar
Pasquali S, Bonvalot S, Tzanis D, Casali PG, Trama A, Gronchi A, et al. RARECARENet Working Group. Treatment challenges in and outside a network setting: Soft tissue Sarcomas. Eur J Surg Oncol 2019; 45: 31-9. doi: 10.1016/j.ejso.2017.09.015PasqualiSBonvalotSTzanisDCasaliPGTramaAGronchiAet alRARECARENet Working Group. Treatment challenges in and outside a network setting: Soft tissue SarcomasEur J Surg Oncol20194531910.1016/j.ejso.2017.09.015Open DOISearch in Google Scholar
International incidence of childhood cancer. Volume III. Steliarova-Foucher E, Colombet M, Ries LAG, Hesseling P, Moreno F, Shin HY, et al, editors. Lyon, France: International Agency for Research on Cancer; 2017. [cited 2020 May 15]. Available at: http://iicc.iarc.fr/results/International incidence of childhood cancer. Volume IIISteliarova-FoucherEColombetMRiesLAGHesselingPMorenoFShinHYet al, editorsLyon, FranceInternational Agency for Research on Cancer2017cited 2020 May 15Available athttp://iicc.iarc.fr/results/Search in Google Scholar
Stevens MC, Rey A, Bouvet N, Ellershaw C, Flamant F, Habrand JL, et al. Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology - SIOP Malignant Mesenchymal Tumor 89. J Clin Oncol 2005; 23: 2618-28. doi: 10.1200/JCO.2005.08.130StevensMCReyABouvetNEllershawCFlamantFHabrandJLet alTreatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology - SIOP Malignant Mesenchymal Tumor 89J Clin Oncol20052326182810.1200/JCO.2005.08.130Open DOISearch in Google Scholar
Bisogno G, De Salvo GL, Bergeron C, Gallego Melcón S, Merks JH, Kelsey A, et al; European paediatric Soft tissue sarcoma Study Group. Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol 2019; 20: 1566-75. doi: 10.1016/S1470-2045(19)30617-5BisognoGDe SalvoGLBergeronCGallegoMelcón SMerksJHKelseyAet alEuropean paediatric Soft tissue sarcoma Study Group. Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trialLancet Oncol20192015667510.1016/S1470-2045(19)30617-5Open DOISearch in Google Scholar
Breneman JC, Lyden E, Pappo AS, Link MP, Anderson JR, Parham DM, et al. Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol 2003; 21: 78-84. doi: 10.1200/JCO.2003.06.129BrenemanJCLydenEPappoASLinkMPAndersonJRParhamDMet alPrognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study IVJ Clin Oncol200321788410.1200/JCO.2003.06.12912506174Open DOISearch in Google Scholar
Koscielniak E, Harms D, Henze G, Jürgens H, Gadner H, Herbst M, et al. Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86. J Clin Oncol 1999; 17: 3706-19. doi: 10.1200/JCO.1999.17.12.3706KoscielniakEHarmsDHenzeGJürgensHGadnerHHerbstMet alResults of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86J Clin Oncol19991737061910.1200/JCO.1999.17.12.370610577842Open DOISearch in Google Scholar
Oberlin O, Rey A, Lyden E, Bisogno G, Stevens MC, Meyer WH, et al. Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups. J Clin Oncol 2008; 26: 2384-9. doi: 10.1200/JCO.2007.14.7207OberlinOReyALydenEBisognoGStevensMCMeyerWHet alPrognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groupsJ Clin Oncol2008262384910.1200/JCO.2007.14.7207Open DOISearch in Google Scholar
Bisogno G, Jenney M, Bergeron C, Gallego Melcón S, Ferrari A, Oberlin O, et al. Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial. Lancet Oncol 2018; 19: 1061-71. doi: 10.1016/S1470-2045(18)30337-1BisognoGJenneyMBergeronCGallegoMelcón SFerrariAOberlinOet alAddition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trialLancet Oncol20181910617110.1016/S1470-2045(18)30337-1Open DOISearch in Google Scholar
Crist WM, Anderson JR, Meza JL, Fryer C, Raney RB, Ruymann FB, et al. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol 2001; 19: 3091-102. doi: 10.1200/ JCO.2001.19.12.309CristWMAndersonJRMezaJLFryerCRaneyRBRuymannFBet alIntergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic diseaseJ Clin Oncol200119309110210.1200/JCO.2001.19.12.309Open DOISearch in Google Scholar
Flamant F, Rodary C, Rey A, Praquin MT, Sommelet D, Quintana, et al. Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology MMT84. Eur J Cancer 1998; 34: 1050-62. doi: 10.1016/s0959-8049(98)00024-0FlamantFRodaryCReyAPraquinMTSommeletDQuintana, et alTreatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology MMT84Eur J Cancer19983410506210.1016/s0959-8049(98)00024-0Open DOISearch in Google Scholar
Koscielniak E, Harms D, Henze G, Jürgens H, Gadner H, Herbst M, et al. Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86. J Clin Oncol 1999; 17: 3706-19. doi: 10.1200/JCO.1999.17.12.3706KoscielniakEHarmsDHenzeGJürgensHGadnerHHerbstMet alResults of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86J Clin Oncol19991737061910.1200/JCO.1999.17.12.3706Open DOISearch in Google Scholar
Cecchetto G, Carli M, Sotti G, Bisogno G, Dall’Igna P, C Boglino, et al. Importance of local treatment in pediatric soft tissue sarcomas with microscopic residual after primary surgery: results of the Italian Cooperative Study RMS-88. Med Pediatr Oncol 2000; 34: 97-101. doi: 10.1002/(sici)1096-911x(200002)34:2<97::aid-mpo4>3.0.co;2-8CecchettoGCarliMSottiGBisognoGDall’IgnaPBoglinoCet alImportance of local treatment in pediatric soft tissue sarcomas with microscopic residual after primary surgery: results of the Italian Cooperative Study RMS-88Med Pediatr Oncol2000349710110.1002/(sici)1096-911x(200002)34:2<97::aid-mpo4>3.0.co;2-8Open DOISearch in Google Scholar
Jereb B, Anžič J. Pediatric oncology in Slovenia. Pediatric Hematol Oncol 1996; 13: 401-4. doi: 10.3109/08880019609030851JerebBAnžičJPediatric oncology in SloveniaPediatric Hematol Oncol199613401410.3109/08880019609030851Open DOISearch in Google Scholar
Ferrari A, Bisogno G, Casanova M, Meazza C, Piva L, Cecchetto G, et al. Paratesticular rhabdomyosarcoma: report from the Italian and German Cooperative Group. J Clin Oncol 2002; 20: 449-55. doi: 10.1200/JCO.2002.20.2.449FerrariABisognoGCasanovaMMeazzaCPivaLCecchettoGet alParatesticular rhabdomyosarcoma: report from the Italian and German Cooperative GroupJ Clin Oncol2002204495510.1200/JCO.2002.20.2.449Open DOISearch in Google Scholar
Stewart RJ, Martelli H, Oberlin O, Rey A, Bouvet N, Spicer RD, et al. Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: results of the Malignant Mesenchymal Tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric Oncology. J Clin Oncol 2003; 21: 793-8. doi: 10.1200/JCO.2003.06.040StewartRJMartelliHOberlinOReyABouvetNSpicerRDet alTreatment of children with nonmetastatic paratesticular rhabdomyosarcoma: results of the Malignant Mesenchymal Tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric OncologyJ Clin Oncol200321793810.1200/JCO.2003.06.040Open DOISearch in Google Scholar
Merks JH, De Salvo GL, Bergeron C, Bisogno G, De Paoli A, Ferrari A, et al. Parameningeal rhabdomyosarcoma in pediatric age: results of a pooled analysis from North American and European cooperative groups. Ann Oncol 2014; 25: 231-6. doi: 10.1093/annonc/mdt426MerksJHDe SalvoGLBergeronCBisognoGDe PaoliAFerrariAet alParameningeal rhabdomyosarcoma in pediatric age: results of a pooled analysis from North American and European cooperative groupsAnn Oncol201425231610.1093/annonc/mdt426Open DOISearch in Google Scholar
Bisogno G, De Rossi C, Gamboa Y, Sotti G, Ferrari A, Dallorso S, et al. Improved survival for children with parameningeal rhabdomyosarcoma: Results from the AIEOP soft tissue sarcoma committee. Pediatr Blood Cancer 2008; 50: 1154-8. doi: 10.1002/pbc.2152BisognoGDe RossiCGamboaYSottiGFerrariADallorsoSet alImproved survival for children with parameningeal rhabdomyosarcoma: Results from the AIEOP soft tissue sarcoma committeePediatr Blood Cancer2008501154810.1002/pbc.2152Open DOISearch in Google Scholar
Minard-Colin V, Kolb F, Saint-Rose C, Fayard F, Janot F, Rey A, et al. Impact of extensive surgery in multidisciplinary approach of pterygopalatine/ infratemporal fossa soft tissue sarcoma. Pediatr Blood Cancer 2013; 60: 928-34. doi: 10.1002/pbc.24374Minard-ColinVKolbFSaint-RoseCFayardFJanotFReyAet alImpact of extensive surgery in multidisciplinary approach of pterygopalatine/ infratemporal fossa soft tissue sarcomaPediatr Blood Cancer2013609283410.1002/pbc.2437423303699Open DOISearch in Google Scholar
Chargari C, Haie-Meder C, Guérin F, Minard-Colin V, de Lambert G, Mazeron R, et al. Brachytherapy combined with surgery for conservative treatment of children with bladder neck and/or prostate rhabdomyosarcoma. Int J Rad Oncol 2017; 98: 352-9. doi: 10.1016/j.ijrobp.2017.02.026ChargariCHaie-MederCGuérinFMinard-ColinVde LambertGMazeronRet alBrachytherapy combined with surgery for conservative treatment of children with bladder neck and/or prostate rhabdomyosarcomaInt J Rad Oncol201798352910.1016/j.ijrobp.2017.02.02628463154Open DOISearch in Google Scholar
Bisogno G, Pastore G, Perilongo G, Sotti G, Cecchetto G, Dallorso S, et al. Long-term results in childhood rhabdomyosarcoma: A report from the Italian cooperative study RMS 79. Pediatr Blood Cancer 2012; 58: 872-6. doi: 10.1002/pbc.23292BisognoGPastoreGPerilongoGSottiGCecchettoGDallorsoSet alLong-term results in childhood rhabdomyosarcoma: A report from the Italian cooperative study RMS 79Pediatr Blood Cancer201258872610.1002/pbc.2329222028198Open DOISearch in Google Scholar
